Cancer and cancer treatment including chemotherapy, radiation, surgery, bone marrow and stem cell transplants, or other conditions may damage the ovary and testicle and cause temporary or permanent infertility. Before you begin treatment that could damage the reproductive system and lead to fertility concerns, you should be aware of your options for preserving fertility. Men, women, and children who are receiving cancer treatment are candidates for fertility preservation. There are many options that include an in vitro fertilization cycle where the ovaries are stimulated with injection medications in a timely fashion to accommodate expedited plans for cancer treatment. This is followed by cryopreservation of the sperm, eggs, or embryos.
Fertility preservation is also an option for other patients who are receiving chemotherapy for treatment of non-cancer conditions such as rheumatoid arthritis, systemic lupus erythematous and autoimmune bowel disease. Fertility preservation is also an option for women against normal aging of the ovaries and for vetrans traveling abroad. Dr. Salih has been the director of the fertility preservation program for years at major academic centers.
- Egg Cryopreservation
- Sperm Cryopreservation
- Embyo Cryopreservation
- Ovarian and Testicular Tissue Cryopreservation
- Medical Therapies (GNRH Agonist such as Lupron, Goserelin)
Ovarian Transposition: Ovaries moved within the pelvis so they can function, but avoid the area receiving radiation therapy. (Note: This process does not protect against chemotherapy.)
Ovarian Shielding: The ovaries are shielded from radiation to minimize damage
Tracheledtomy: The uterine cervis is surgically removed and the uterus and ovaries are conserved. This may be an option for younger woman with early cervical cancer.